SEOUL, Oct. 28 (Yonhap) -- Yuhan Corp., a South Korean biopharmaceutical company, said Monday its third-quarter net profit ...

Yuhan-Kimberly, a joint venture between Korea’s Yuhan Corp. and America’s Kimberly Clark, has been chosen as one of the ...

Yuhan stands to potentially receive up to $1.25 billion in potential development and commercial milestone payments, along with tiered double-digit royalties on future net sales.

Gilead Sciences has abandoned a liver disease collaboration with Yuhan. A new study suggests Leqembi's vial design could cost Medicare hundreds of millions of dollars in waste each year.

J INTS BIO will oversee the entire project, managing clinical trials to validate AI-based predictions and develop clinically ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Yuhan Zhang is a seasoned economist and adviser with over 15 years of research and professional experience in both the public and private sectors, specialising in China's economy, investment valuation ...

4 Women's 4 x 200m Freestyle Relay 7:47.96 3 Women's 4 x 200m Freestyle Relay, Heats 7:49.58 Q 2 Women's 4 x 200m Freestyle Relay, Heats, Heat 2 7:49.58 4 Women's 4 x 200m Freestyle Relay, Final 7 ...

Yuhan Li is Associate Director of Learning Design in the Center for Digital Innovation in Learning at Boston College. With nearly 8 years of experience supporting faculty teaching in higher education, ...